Global pharmaceuticals · Operating model & governance

Creating clearer governance for pharmaceutical development

A more coherent governance and enabling-operations model for a complex global drug-development organisation.

10+ workstreamsGovernance &EnablingOperations modelAbout 1,500 FTEs in scope
ExhibitMany workstreams, one governance model
  • 1,500

    FTEs in scope

  • 10+

    workstreams

The challenge

The development function needed clearer decision forums, hand-offs and partnership responsibilities. Controls and performance information also had to work across clinical development.

Our approach

  • Supported governance workshops with the leadership team.
  • Designed a Governance & Enabling Operations model.
  • Mapped end-to-end processes and organisational interfaces.
  • Linked new responsibilities to milestones, risk management, reporting and transition requirements.

What we delivered

  • Governance design options
  • Process and interface maps
  • Organisation-design inputs and management materials
  • An integrated implementation plan

Client details are anonymised to protect confidentiality.

Discuss a challenge with us

Facing a similar question?

We would welcome a conversation about the challenge and what good could look like.